Literature DB >> 28587434

Diagnostic accuracy of diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion for the detection of abdominal solid cancer.

Minoru Tomizawa1, Fuminobu Shinozaki2, Kazunori Fugo3, Satomi Tanaka2, Takafumi Sunaoshi2, Daisuke Kano2, Eriko Sugiyama2, Misaki Shite2, Ryouta Haga2, Yoshiya Fukamizu2, Toshiyuki Fujita2, Satoshi Kagayama2, Rumiko Hasegawa4, Akira Togawa4, Yoshinori Shirai4, Noboru Ichiki4, Yuji Oshima5, Naoto Koike5, Yasuko Toshimitsu6, Yasufumi Motoyoshi7, Takao Sugiyama8, Shigenori Yamamoto9, Takashi Kishimoto3, Naoki Ishige10.   

Abstract

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) images show significant contrast for cancer tissues against non-cancerous tissues. Fusion of a DWIBS and a T2-weighted image (DWIBS/T2) can be used to obtain functional, as well as anatomic, information. In the present study, the performance of DWIBS/T2 in the diagnosis of abdominal solid cancer was evaluated. The records of 14 patients were retrospectively analyzed [5 patients with hepatocellular carcinoma (HCC), 4 with metastatic liver cancer, 3 with pancreatic cancer, 1 with renal cellular carcinoma and 1 with malignant lymphoma of the para-aortic lymph node]. T1WI and T2WI scans did not detect pancreatic cancer in certain cases, whereas DWIs and DWIBS/T2 clearly demonstrated pancreatic cancer in all cases. In addition, metastatic liver cancer and HCC were successfully detected with abdominal US and CECT; however, US did not detect pancreatic cancer in 1 case, while CECT and DWIBS/T2 detected pancreatic cancer in all cases. In conclusion, the diagnostic performance of DWIBS/T2 was the same as that of abdominal US and CECT in detecting primary and metastatic liver cancer. DWIBS/T2 enabled the diagnosis of pancreatic cancer in cases where it was not detected with US, T1WI or T2WI.

Entities:  

Keywords:  abdominal ultrasonography; computed tomography; hepatocellular carcinoma; pancreatic cancer

Year:  2017        PMID: 28587434      PMCID: PMC5450632          DOI: 10.3892/etm.2017.4432

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  28 in total

1.  High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results.

Authors:  Tomoaki Ichikawa; Sukru Mehmet Erturk; Utarou Motosugi; Hironobu Sou; Hiroshi Iino; Tsutomu Araki; Hideki Fujii
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

Review 2.  Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know.

Authors:  Trevor A Rose; Jung W Choi
Journal:  Am J Med       Date:  2015-03-27       Impact factor: 4.965

4.  Diffusion weighted imaging with background body signal suppression / T2 image fusion in magnetic resonance mammography for breast cancer diagnosis.

Authors:  I A Nechifor-Boilă; S Bancu; M Buruian; M Charlot; M Decaussin-Petrucci; J-S Krauth; A C Nechifor-Boilă; A Borda
Journal:  Chirurgia (Bucur)       Date:  2013 Mar-Apr

5.  Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study.

Authors:  A Stecco; G Romano; M Negru; D Volpe; A Saponaro; S Costantino; G Sacchetti; E Inglese; O Alabiso; A Carriero
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

6.  Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Yumiko Onishi; Daisuke Takenaka; Munenobu Nogami; Takeshi Yoshikawa; Sumiaki Matsumoto; Yoshikazu Kotani; Kazuro Sugimura
Journal:  Radiology       Date:  2008-06-06       Impact factor: 11.105

7.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

Authors:  Taro Takahara; Yutaka Imai; Tomohiro Yamashita; Seiei Yasuda; Seiji Nasu; Marc Van Cauteren
Journal:  Radiat Med       Date:  2004 Jul-Aug

8.  Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.

Authors:  Sinan Akay; Murat Kocaoglu; Ozdes Emer; Bilal Battal; Nuri Arslan
Journal:  J Med Imaging Radiat Oncol       Date:  2013-01-07       Impact factor: 1.735

9.  Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.

Authors:  Yusuke Sakurai; Hisashi Kawai; Shingo Iwano; Shinji Ito; Hiroshi Ogawa; Shinji Naganawa
Journal:  J Med Imaging Radiat Oncol       Date:  2012-12-28       Impact factor: 1.735

Review 10.  Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques.

Authors:  Rajpaul Attariwala; Wayne Picker
Journal:  J Magn Reson Imaging       Date:  2013-08       Impact factor: 4.813

View more
  1 in total

Review 1.  The diagnostic performance of contrast-enhanced CT versus extracellular contrast agent-enhanced MRI in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.

Authors:  Xi Chen; Mingkai Li; Ruomi Guo; Weimin Liu; Jianwen Li; Xiaodan Zong; Qilong Chen; Jin Wang
Journal:  Abdom Radiol (NY)       Date:  2022-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.